Triflupromazine - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for triflupromazine and what is the scope of patent protection?
Triflupromazine
is the generic ingredient in one branded drug marketed by Apothecon and Bristol Myers Squibb, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.There are two drug master file entries for triflupromazine.
Summary for triflupromazine
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 2 |
| NDAs: | 3 |
| Drug Master File Entries: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 29 |
| Patent Applications: | 5,968 |
| DailyMed Link: | triflupromazine at DailyMed |
Medical Subject Heading (MeSH) Categories for triflupromazine
Anatomical Therapeutic Chemical (ATC) Classes for triflupromazine
US Patents and Regulatory Information for triflupromazine
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apothecon | VESPRIN | triflupromazine hydrochloride | INJECTABLE;INJECTION | 011325-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bristol Myers Squibb | VESPRIN | triflupromazine hydrochloride | TABLET;ORAL | 011123-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Apothecon | VESPRIN | triflupromazine hydrochloride | INJECTABLE;INJECTION | 011325-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Apothecon | VESPRIN | triflupromazine hydrochloride | INJECTABLE;INJECTION | 011325-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Apothecon | VESPRIN | triflupromazine | SUSPENSION;ORAL | 011491-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
